Efficacy and safety of insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi 1:1) in Japanese patients with type 2 diabetes mellitus inadequately controlled on oral antidiabetic drugs: A randomized, 26-week, open-label, multicenter study:
| Image |  |
|---|---|
| Description | scientific article published on 14 April 2020 |
| Author/s |
author: Atsushi Amano Yasuo Terauchi |
| Publication date | April 14, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |